Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$0.35 - $0.53 $922 - $1,396
-2,635 Reduced 4.78%
52,475 $26,000
Q3 2023

Nov 09, 2023

BUY
$0.38 - $0.58 $18,236 - $27,835
47,992 Added 674.23%
55,110 $21,000
Q2 2023

Aug 11, 2023

SELL
$0.39 - $0.94 $308,877 - $744,474
-791,994 Reduced 99.11%
7,118 $3,000
Q1 2023

May 12, 2023

SELL
$0.79 - $1.91 $92,847 - $224,478
-117,528 Reduced 12.82%
799,112 $655,000
Q4 2022

Feb 08, 2023

BUY
$1.41 - $2.5 $865,758 - $1.54 Million
614,013 Added 202.89%
916,640 $1.43 Million
Q3 2022

Nov 10, 2022

SELL
$1.66 - $2.79 $500,685 - $841,514
-301,618 Reduced 49.92%
302,627 $522,000
Q2 2022

Aug 10, 2022

SELL
$1.44 - $3.98 $1.49 Million - $4.12 Million
-1,035,767 Reduced 63.16%
604,245 $1.05 Million
Q1 2022

May 16, 2022

BUY
$2.97 - $5.2 $2.43 Million - $4.25 Million
817,297 Added 99.34%
1,640,012 $5.89 Million
Q4 2021

Feb 14, 2022

BUY
$4.99 - $7.46 $1.82 Million - $2.73 Million
365,577 Added 79.97%
822,715 $4.11 Million
Q3 2021

Nov 15, 2021

BUY
$7.16 - $9.69 $2.58 Million - $3.5 Million
360,844 Added 374.73%
457,138 $3.27 Million
Q2 2021

Aug 13, 2021

SELL
$6.23 - $10.03 $73,183 - $117,822
-11,747 Reduced 10.87%
96,294 $892,000
Q1 2021

May 12, 2021

BUY
$8.81 - $16.96 $446,896 - $860,312
50,726 Added 88.5%
108,041 $1 Million
Q4 2020

Feb 11, 2021

BUY
$8.5 - $12.85 $26,970 - $40,773
3,173 Added 5.86%
57,315 $507,000
Q3 2020

Nov 12, 2020

BUY
$9.57 - $27.05 $31,762 - $89,778
3,319 Added 6.53%
54,142 $628,000
Q2 2020

Jul 31, 2020

BUY
$7.14 - $31.69 $126,185 - $560,057
17,673 Added 53.31%
50,823 $1.37 Million
Q1 2020

May 01, 2020

SELL
$2.98 - $14.09 $279,023 - $1.32 Million
-93,632 Reduced 73.85%
33,150 $246,000
Q4 2019

Feb 14, 2020

BUY
$1.97 - $3.72 $104,967 - $198,212
53,283 Added 72.49%
126,782 $419,000
Q3 2019

Nov 14, 2019

BUY
$2.05 - $3.02 $115,720 - $170,475
56,449 Added 331.08%
73,499 $151,000
Q2 2019

Aug 14, 2019

SELL
$2.29 - $4.1 $601,610 - $1.08 Million
-262,712 Reduced 93.91%
17,050 $50,000
Q1 2019

May 14, 2019

SELL
$3.34 - $5.1 $766,459 - $1.17 Million
-229,479 Reduced 45.06%
279,762 $1.04 Million
Q4 2018

Feb 14, 2019

BUY
$3.89 - $6.11 $917,903 - $1.44 Million
235,965 Added 86.35%
509,241 $2.04 Million
Q3 2018

Nov 14, 2018

SELL
$3.92 - $5.58 $55,209 - $78,588
-14,084 Reduced 4.9%
273,276 $1.52 Million
Q2 2018

Aug 14, 2018

SELL
$3.88 - $5.16 $603,468 - $802,550
-155,533 Reduced 35.12%
287,360 $1.13 Million
Q1 2018

May 15, 2018

BUY
$4.05 - $5.69 $1.1 Million - $1.54 Million
270,373 Added 156.72%
442,893 $2.09 Million
Q4 2017

Feb 14, 2018

SELL
$4.13 - $6.68 $532,654 - $861,532
-128,972 Reduced 42.78%
172,520 $713,000
Q3 2017

Nov 14, 2017

BUY
$5.36 - $6.37 $654,359 - $777,662
122,082 Added 68.05%
301,492 $1.91 Million
Q2 2017

Aug 14, 2017

BUY
N/A
18,000 Added 11.15%
179,410 $1.41 Million
Q1 2017

Nov 14, 2017

BUY
N/A
161,410
161,410 $1.07 Million

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $1.41B
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.